Ranclav 1 g Film-coated tablets
PDF Leaflet Revision Date: 14 April 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of infections caused by amoxicillin resistant organisms.
Dosage (summary)
1 tablet every 12 hours at the start of a meal for adults.
Special Populations
- Impaired renal function
- Impaired hepatic function
Pregnancy & Breastfeeding
Safety in pregnancy not established; caution in lactation due to potential infant effects.
Key Drug Interactions
- Probenecid may increase amoxicillin levels
- May reduce efficacy of oral contraceptives
Contraindications
- Hypersensitivity to penicillins
- History of jaundice/hepatic dysfunction with amoxicillin/clavulanic acid
Common side effects
- Diarrhoea
- Nausea
- Vomiting
- Skin rashes
- Headache
Counselling Points
- Take before meals
- Maintain adequate fluid intake
- Monitor for allergic reactions
Serious warnings
- Serious hypersensitivity reactions
- Risk of pseudomembranous colitis
Important Disclaimer
The Ranclav 1 g Film-coated tablets professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
